Skip to content
← Back to this collection

PUBLICATIONS · 37016270

Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer Med
Publication date
2023 May
First author
Allen-Rhoades W

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Allen-Rhoades W
      type
      Author
    2. name
      Lupo PJ
      type
      Author
    3. name
      Scheurer ME
      type
      Author
    4. name
      Chi YY
      type
      Author
    5. name
      Kuttesch JF
      type
      Author
    6. name
      Venkatramani R
      type
      Author
    7. name
      Meyer WH
      type
      Author
    8. name
      Mascarenhas L
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Allen-Rhoades W
      type
      Author
    2. name
      Lupo PJ
      type
      Author
    3. name
      Scheurer ME
      type
      Author
    4. name
      Chi YY
      type
      Author
    5. name
      Kuttesch JF
      type
      Author
    6. name
      Venkatramani R
      type
      Author
    7. name
      Meyer WH
      type
      Author
    8. name
      Mascarenhas L
      type
      Author
    bibliography ids
    1. nci-bib-8c3c7650e3745fe62d2da29a
    book metadata
    content sha256
    afc6b7a6afd9bbd16f94dd5ad9744bf472824deced2a9ef05dcc35ad273859ce
    document type
    citation
    dois
    1. 10.1002/cam4.5749
    electronic publication date
    display
    2023 Apr 4
    precision
    day
    year
    2023
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:37016270
    immutable id
    pubmed:37016270@afc6b7a6afd9bbd16f94dd5ad9744bf472824deced2a9ef05dcc35ad273859ce
    journal
    abbreviation
    Cancer Med
    issn electronic
    2045-7634
    issn print
    Source null
    issue
    9
    name
    Cancer medicine
    nlm unique id
    101595310
    pages
    10222-10229
    volume
    12
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      37016270
      provenance
      batch id
      5329a5d0877ee70ecd11
      provider
      NCBI PubMed ESummary
      record sha256
      29f9659aad05c212ffb1627dfd97fa005a30e5534f3f5a9760f8be79e7fb9286
      response sha256
      bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
      retrieved at
      2026-09-09T23:48:15.763286+00:00
      publication date
      display
      2023 May
      precision
      month
      year
      2023
      publication types
      1. Meta-Analysis
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/37016270/
      title
      Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis.

      Preserved source evidence · Not medical advice